Determination of anatomic level of myelomeningocele by prenatal ultrasound
- PMID: 35178598
- DOI: 10.1007/s00381-022-05469-9
Determination of anatomic level of myelomeningocele by prenatal ultrasound
Abstract
Purpose: Ultrasound is the primary method for prenatal identification of myelomeningocele and is critical to prognostication and treatment planning. No study has considered the degree of inaccuracy of prenatal US lesion level estimates and anatomic lesion level on postnatal imaging using the weighted kappa coefficient (κw), nor the impact of maternal BMI on agreement. We examined the accuracy of prenatal ultrasound lesion level estimation in a cohort of patients with myelomeningocele using κw and determined whether BMI influenced accuracy.
Methods: The study is a retrospective review including patients born 2011-2019 who had prenatal imaging and primary myelomeningocele closure at a single institution. Lesion levels from prenatal ultrasound and postnatal imaging studies were analyzed for agreement at exact level, within 1 level, and within 2 levels using κw. Maternal BMI was examined for correlation with accuracy.
Results: Fifty-seven patients met inclusion criteria. Mean BMI was 31.2. There was no association between maternal BMI and agreement at any level. Lesion level on prenatal ultrasound agreed with postnatal imaging to the exact level in 13 (22.8%) cases, within 1 level in 38 (66.7%) cases, and within 2 levels in 50 (87.7%) cases. Weighted kappa showed moderate agreement at exact level (κw = 0.494) and substantial agreement within 1 (κw = 0.761) and 2 levels (κw = 0.902).
Conclusion: Weighted kappa adds confidence for clinical decision making by accounting for accuracy. Prenatal ultrasound is a reliable and accurate method of determining lesion level with near-perfect agreement to postnatal imaging within 2 spinal levels. Maternal BMI may not influence lesion level determination after initial diagnosis.
Keywords: Accuracy; Lesion level; Myelomeningocele; Radiology.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Aaronson OS, Hernanz-Schulman M, Bruner JP, Reed GW, Tulipan NB (2003) Myelomeningocele: prenatal evaluation–comparison between transabdominal US and MR imaging. Radiology 227:839–843. https://doi.org/10.1148/radiol.2273020535 - DOI - PubMed
-
- Appasamy M, Roberts D, Pilling D, Buxton N (2006) Antenatal ultrasound and magnetic resonance imaging in localizing the level of lesion in spina bifida and correlation with postnatal outcome. Ultrasound Obstet Gynecol 27:530–536. https://doi.org/10.1002/uog.2755 - DOI - PubMed
-
- Coleman BG, Langer JE, Horii SC (2015) The diagnostic features of spina bifida: the role of ultrasound. Fetal Diagn Ther 37:179–196. https://doi.org/10.1159/000364806 - DOI - PubMed
-
- Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL, Investigators M (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993–1004. https://doi.org/10.1056/NEJMoa1014379 - DOI - PubMed - PMC
-
- Farmer DL, Thom EA, Brock JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Gupta N, Adzick NS, MoMS Investigators (2018) The management of myelomeningocele study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 218:256.e251-256.e213. https://doi.org/10.1016/j.ajog.2017.12.001 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous